163 related articles for article (PubMed ID: 37293256)
41. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
Palma L; Celli P; Franco C; Cervoni L; Cantore G
J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894
[TBL] [Abstract][Full Text] [Related]
42. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
43. A molecularly integrated grade for meningioma.
Driver J; Hoffman SE; Tavakol S; Woodward E; Maury EA; Bhave V; Greenwald NF; Nassiri F; Aldape K; Zadeh G; Choudhury A; Vasudevan HN; Magill ST; Raleigh DR; Abedalthagafi M; Aizer AA; Alexander BM; Ligon KL; Reardon DA; Wen PY; Al-Mefty O; Ligon AH; Dubuc AM; Beroukhim R; Claus EB; Dunn IF; Santagata S; Bi WL
Neuro Oncol; 2022 May; 24(5):796-808. PubMed ID: 34508644
[TBL] [Abstract][Full Text] [Related]
44. World Health Organization grade II meningiomas.
Champeaux C; Dunn L
Acta Neurochir (Wien); 2016 May; 158(5):921-9; discussion 929. PubMed ID: 27020441
[TBL] [Abstract][Full Text] [Related]
45. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
46. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
47. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant Radiotherapy Did Not Reduce Recurrence of World Health Organization Grade I Meningiomas with Venous Sinus Involvement: A Propensity Score Adjusted Analysis and Literature Review.
Gomes Dos Santos A; Solla DJF; Moscardi R; Neville IS; Weltman E; Teixeira MJ; Paiva WS
World Neurosurg; 2019 Oct; 130():e1015-e1019. PubMed ID: 31306847
[TBL] [Abstract][Full Text] [Related]
49. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
[TBL] [Abstract][Full Text] [Related]
50. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
52. Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
Le Van T; Graillon T; Jacob J; Vauleon E; Feuvret L; Boch AL; Boetto J; Boone M; Bronnimann C; Caire F; De Barros A; Delaitre M; Di Stefano AL; Dore M; Ducray F; Dufour C; Engelhardt J; Fontaine D; Froelich S; Helleringer M; Huchet A; Joncour A; Jouanneau E; Mallereau CH; Monfilliette A; Le Fur E; Zemmoura I; Chinot O; Sanson M; Kalamarides M; Loiseau H; Peyre M
J Neurooncol; 2021 May; 153(1):55-64. PubMed ID: 33778930
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.
Deng M; Hinz F; Harrabi S; Sturm D; Sill M; Korshunov A; Eichkorn T; Hörner-Rieber J; Herfarth K; Jungk C; Unterberg A; Pfister S; Wick W; von Deimling A; Jones D; Debus J; Sahm F; König L
Neurooncol Pract; 2023 Jun; 10(3):307-314. PubMed ID: 37188167
[TBL] [Abstract][Full Text] [Related]
54. Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review.
Belanger K; Ung TH; Damek D; Lillehei KO; Ormond DR
BMC Cancer; 2022 Apr; 22(1):367. PubMed ID: 35392834
[TBL] [Abstract][Full Text] [Related]
55. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
[TBL] [Abstract][Full Text] [Related]
56. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
[TBL] [Abstract][Full Text] [Related]
57. Is the Simpson Grading System Applicable to Estimate the Risk of Tumor Progression After Microsurgery for Recurrent Intracranial Meningioma?
Schipmann S; Schwake M; Sporns PB; Voß KM; Sicking J; Spille DC; Hess K; Paulus W; Stummer W; Brokinkel B
World Neurosurg; 2018 Nov; 119():e589-e597. PubMed ID: 30081236
[TBL] [Abstract][Full Text] [Related]
58. Classification of human meningiomas: lights, shadows, and future perspectives.
Barresi V; Caffo M; Tuccari G
J Neurosci Res; 2016 Dec; 94(12):1604-1612. PubMed ID: 27376782
[TBL] [Abstract][Full Text] [Related]
59. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
60. Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
Valery CA; Faillot M; Lamproglou I; Golmard JL; Jenny C; Peyre M; Mokhtari K; Mazeron JJ; Cornu P; Kalamarides M
J Neurosurg; 2016 Dec; 125(Suppl 1):89-96. PubMed ID: 27903189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
